Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04314089
Title Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Edward Patz
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.